The approval for the vaccine, Abrysvo, in adults aged 18 to 59 was based on the results from a late stage trial in which two doses of the vaccine were teste ...

Up to 10,000 Brits a day are getting a new variant of coronavirus called XEC, which is a mixture of the Delta and Omicron ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Much good can go unnoticed. There are successes leading to healthier and longer lives – even in my chaotic specialty.

A mother whose newborn son almost died after contracting a respiratory virus is warning others not to its "underestimate" symptoms. Just two weeks after Gemma gave birth to her son Harry in December ...

Dr Xand van Tulleken has addressed public confusion surrounding different types of vaccination, amid fears of a "tripledemic" ...

There’s been an uptick in viral infections in the post-pandemic period, but that isn’t necessarily a bad thing.View on ...

A record number of patients attended Bolton Royal Hospital's Emergency Department last week. The unusually high number of people occurred on Monday (October 14), with medical staff seeing to a total ...

Dr Xand's thoughts comes amidst rising concern over a 'tripledemic' this winter, as cases of people catching Covid, flu and ...

Pneumonia may inflame the air sacs in one or both of your lungs, notes the Mayo Clinic. The sacs can fill with pus or fluid, ...

Pfizer (PFE) announced that the U.S. FDA has approved Abrysvo, the company’s bivalent RSV prefusion F vaccine, for the prevention of ...

Tuesday's approval makes Abrysvo the first RSV vaccine indicated for adults younger than 50, the biopharmaceutical company said. Last year, it was approved for use by those 60 years and older, as well ...